Morpheus8MAX
Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639
Morpheus8MAX
ELEVATING FRACTIONAL OUTCOMES
WHAT IS MORPHEUS8MAX?
Morpheus8, the #1 radiofrequency microneedling procedure in the world, is redefining the gold standard by elevating it to an entirely new level of comfort and control. Morpheus8MAX is an expandable platform designed to support stackable modalities, including the Morpheus8 Cool handpiece, the Erbia* Er:YAG technology, and future modalities.
KEY BENEFITS:
- Expandable platform designed to support multiple stackable modalities available exclusively on Morpheus8MAX:
• Morpheus8 Cool
• Erbia* Er:YAG Laser - Interactive User Interface and Intelligent Series Software engineered for enhanced control and safety, without compromising efficacy.
- Engineered to deliver combination fractional procedures.
- Provides the versatility for tailored treatment plans based on patient skin type, anatomy, and concerns.
*Erbia is pending FDA approval.
TECHNOLOGIES ON THE WORKSTATION
MORPHEUS8 COOL
Morpheus8 Cool by InMode features a newly engineered handpiece and 24 pin Cooling Tip built to maximize comfort, precision, and safety. Its large surface plate, with a built-in surface cooling feature, intelligently manages the thermal experience with every pulse. The Interactive User Interface and Intelligent Series Software offer an enhanced level of control prioritizing results and safety, without compromising efficacy. Practitioners can either select Guided Mode or Manual Mode to deliver proven Morpheus8 radiofrequency soft tissue contraction.
ERBIA
Erbia* by InMode delivers an efficient 2940 nm wavelength for controlled reliable results. Erbia’s Er:YAG energy is absorbed at the dermal level, limiting heat spread beyond the treatment zone and into surrounding tissue. The result is less erythema, less swelling, and a lower risk of post-inflammatory pigmentation. Dual Fractional and Surgical Modes allow for broad resurfacing and focused precision procedures.
*Erbia is pending FDA approval.
Approved intended use varies by country; please check with local providers or representatives. Individual treatment results may vary.
Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.
